Molecular impediments to fate-specifying pioneer factor activity during development
发育过程中决定命运的先锋因子活动的分子障碍
基本信息
- 批准号:10363623
- 负责人:
- 金额:$ 3.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-03 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAddressAwardBase PairingBindingBiologicalBiological ModelsBuffersCell Differentiation processCell Fate ControlCellsChromatinChromatin StructureConflict (Psychology)ConsumptionDNADNA BindingDNA SequenceDevelopmentDevelopmental GeneDiseaseDownstream EnhancerEducational StatusEnhancersEnsureEnvironmentEquilibriumEventExcisionFoundationsFutureGene ExpressionGene Expression RegulationGenesGenetic Enhancer ElementGenetic TranscriptionGenomeHeterogeneityHistonesHypoxiaImageMaintenanceMalignant NeoplasmsMeasuresMetabolicMetabolic ControlMetabolismMethodsModelingMolecularMutationNucleosomesOutcomeOxygenPhasePlayPluripotent Stem CellsProcessRegulationRegulator GenesResearchResolutionRoleS-AdenosylhomocysteineSiteSpecific qualifier valueStructureSystemTechniquesTechnologyTestingTimeTrainingVariantbasecareercell typechromatin remodelingdevelopmental diseaseembryonic stem cellepigenomeepigenomicsexpectationexperienceexperimental analysisexperimental studygenetic manipulationimprovedin vivoinnovationinsightmetabolomicsnovelpreventprogramsresponsescreeningstem cell differentiationstem cellstheoriestranscription factor
项目摘要
Project Summary/Abstract
Transcription factors act as specifying agents of cell differentiation during development by binding to DNA
enhancer sequences and activating them to control developmental gene expression. Enhancer activation is
typically associated with the removal of nucleosomes, which decorate eukaryotic genomes and normally wrap
roughly 150 base pairs of DNA in a highly stable configuration. A persistent puzzle of developmental gene
regulation is how TFs bind and activate their target enhancers when they are initially wrapped in nucleosomes,
which typically inhibit TF binding. One hypothesis posits that a special class of “pioneer factors” are able to bind
their targets in the context of nucleosomal wrapping and displace the nucleosomes they bind to activate and
expose the enhancer for downstream TF binding. However, it has been exceedingly difficult to confirm the
presence of nucleosome binding “pioneer activity” in vivo, leaving the developmental roles of pioneer factors in
question. We recently used high-resolution epigenome profiling to identify instances of nucleosome binding by
pioneer factors that were enriched at enhancers with suboptimal motif binding sequences, presenting the
intriguing possibility that pioneer activity is a mechanism to ensure the fidelity of enhancer activation at sites that
are vulnerable to natural fluctuations in the local chromatin environment. Pioneer factors often function in early
development, which maintains high fidelity despite natural variation in chromatin structure that is sensitive to the
metabolic state of the cell. Therefore, pioneer factors may play a direct role in insulating developmental
transitions against metabolic variance. However, the potential roles of pioneer factors in developmental fidelity
and buffering against metabolic heterogeneity have not been uncovered to date. In this proposal, I will use a
controlled pioneer factor expression system to study how pioneer factor-driven developmental changes are
buffered against deliberate chromatin and metabolic perturbations. In Aim 1, I will test the hypothesis that pioneer
activity facilitates developmental fidelity by observing development after genetically enforcing chromatin barriers
to pioneer factor binding and inactivating the nucleosome binding pioneer activity of a specific pioneer factor. In
Aim 2, I will use a model system of metabolic control of development to understand how pioneer factor binding
responds to metabolic changes, and how specific pioneer factor-enhancer activation events underlie different
developmental outcomes in response. These Aims will uncover mechanistic explanations for the disparity
between variance in gene regulatory processes on the molecular level and the precision of cell fate outcomes
on the developmental level, and my findings will be of direct consequence to diseases such as cancer where
extreme heterogeneity overwhelms the checks and balances on cell fate. A K99/R00 Award will be instrumental
in addressing these questions and furnishing me with high level training in new methods and biological theory
that will prepare me to continue to pursue major research avenues related to pioneer factor and chromatin control
of development in my future independent career.
项目总结/文摘
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multifactorial profiling of epigenetic landscapes at single-cell resolution using MulTI-Tag.
- DOI:10.1038/s41587-022-01522-9
- 发表时间:2023-05
- 期刊:
- 影响因子:46.9
- 作者:Meers, Michael P.;Llagas, Geneva;Janssens, Derek H.;Codomo, Christine A.;Henikoff, Steven
- 通讯作者:Henikoff, Steven
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael P Meers其他文献
Michael P Meers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael P Meers', 18)}}的其他基金
Molecular impediments to fate-specifying pioneer factor activity during development
发育过程中决定命运的先锋因子活动的分子障碍
- 批准号:
10732456 - 财政年份:2021
- 资助金额:
$ 3.8万 - 项目类别:
Analyzing pioneer factor dynamics and function during differentiation and reprogramming
分析分化和重编程过程中先锋因子的动态和功能
- 批准号:
9911897 - 财政年份:2020
- 资助金额:
$ 3.8万 - 项目类别:
Studying the role of H3K36 methylation in development and gene expression
研究 H3K36 甲基化在发育和基因表达中的作用
- 批准号:
8649283 - 财政年份:2014
- 资助金额:
$ 3.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.8万 - 项目类别:
Research Grant